Search research articles
Contact Us
Filters
Showing results (51-60 of 150) with videos related to
Page
of 15
Sort By:
Frontiers in Oncology
|
July 11, 2025
Sex differences in toxicity and outcomes in patients with sarcoma treated in the perioperative setting at a comprehensive cancer center
Ilaria Tortorelli, Benedetta Chiusole, Fabio Murtas, et al.
BMC Cancer
|
June 24, 2024
International multicenter real-world REGistry for patients with metastatic renAL cell carcinoma - Meet-URO 33 study (REGAL study)
Sara Elena Rebuzzi, Giuseppe Fornarini, Alessio Signori, et al.
Current Oncology (Toronto, Ont.)
|
November 10, 2022
Patient-Factors Influencing the 2-Year Trajectory of Mental and Physical Health in Prostate Cancer Patients
Alessandro Cicchetti, Marianna Noale, Paola Dordoni, et al.
Clinical Genitourinary Cancer
|
November 7, 2018
Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 Study
Cristina Masini, Maria Giuseppa Vitale, Marco Maruzzo, et al.
Anticancer Research
|
October 3, 2018
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma
Matteo Santoni, Francesco Piva, Ugo De Giorgi, et al.
Frontiers in Oncology
|
September 2, 2022
Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors
Giandomenico Roviello, Martina Catalano, Ugo De Giorgi, et al.
Oncotarget
|
July 14, 2016
Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib
Cristian Lolli, Umberto Basso, Lisa Derosa, et al.
Frontiers in Oncology
|
July 3, 2020
Extraskeletal Myxoid Chondrosarcoma: Clinical and Molecular Characteristics and Outcomes of Patients Treated at Two Institutions
Benedetta Chiusole, Axel Le Cesne, Marco Rastrelli, et al.
Patient Preference and Adherence
|
February 17, 2022
Cancer Patient-Reported Experience Measures (PREMs) Regarding the Policies Implemented to Contain the Spread of Sars-CoV-2 and Vaccination Campaign at Veneto Institute of Oncology
Mario Caccese, Silvia Imbevaro, Alessandra Feltrin, et al.
Critical Reviews in Oncology/Hematology
|
March 6, 2021
Second medical opinion in oncological setting
Marco Maruzzo, Nicla La Verde, Antonio Russo, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 150) with videos related to
Sort By:
Page
of 15
Frontiers in Oncology
|
July 11, 2025
Sex differences in toxicity and outcomes in patients with sarcoma treated in the perioperative setting at a comprehensive cancer center
Ilaria Tortorelli, Benedetta Chiusole, Fabio Murtas, et al.
BMC Cancer
|
June 24, 2024
International multicenter real-world REGistry for patients with metastatic renAL cell carcinoma - Meet-URO 33 study (REGAL study)
Sara Elena Rebuzzi, Giuseppe Fornarini, Alessio Signori, et al.
Current Oncology (Toronto, Ont.)
|
November 10, 2022
Patient-Factors Influencing the 2-Year Trajectory of Mental and Physical Health in Prostate Cancer Patients
Alessandro Cicchetti, Marianna Noale, Paola Dordoni, et al.
Clinical Genitourinary Cancer
|
November 7, 2018
Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 Study
Cristina Masini, Maria Giuseppa Vitale, Marco Maruzzo, et al.
Anticancer Research
|
October 3, 2018
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma
Matteo Santoni, Francesco Piva, Ugo De Giorgi, et al.
Frontiers in Oncology
|
September 2, 2022
Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors
Giandomenico Roviello, Martina Catalano, Ugo De Giorgi, et al.
Oncotarget
|
July 14, 2016
Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib
Cristian Lolli, Umberto Basso, Lisa Derosa, et al.
Frontiers in Oncology
|
July 3, 2020
Extraskeletal Myxoid Chondrosarcoma: Clinical and Molecular Characteristics and Outcomes of Patients Treated at Two Institutions
Benedetta Chiusole, Axel Le Cesne, Marco Rastrelli, et al.
Patient Preference and Adherence
|
February 17, 2022
Cancer Patient-Reported Experience Measures (PREMs) Regarding the Policies Implemented to Contain the Spread of Sars-CoV-2 and Vaccination Campaign at Veneto Institute of Oncology
Mario Caccese, Silvia Imbevaro, Alessandra Feltrin, et al.
Critical Reviews in Oncology/Hematology
|
March 6, 2021
Second medical opinion in oncological setting
Marco Maruzzo, Nicla La Verde, Antonio Russo, et al.
Page
of 15